‘Everything Is Up For Grabs’ – Alvotech’s Wessman On Biosimilar Streamlining And Bridging The Void

CEO Also Proposes Targeting Offshoring As Alternative To US Tariffs

 
• By Dave Wallace
  
Róbert Wessman reflects on the current policy and regulatory environment (Alvotech)

More from Interviews

More from Leadership